Biodesix (BDSX) Other Non-Current Assets (2019 - 2026)
Biodesix's (BDSX) quarterly Other Non-Current Assets came in at $7.9 million in Q1 2026, up 7.71% YoY from $7.3 million in Q1 2025, and down 4.46% on a QoQ basis from $8.2 million in Q4 2025.
Biodesix (BDSX) Other Non-Current Assets (2019 - 2026) Analysis & Trends
Biodesix (BDSX) has 8 years of Other Non-Current Assets data on file, last reported at $7.9 million in Q1 2026.
- Quarterly Other Non-Current Assets rose 7.71% year-over-year to $7.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $7.9 million (up 7.71% YoY) and the FY2025 annual result came in at $8.2 million, up 13.36% from the prior year.
- Other Non-Current Assets slipped to $7.9 million in Q1 2026, from $8.2 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $8.2 million in Q4 2025 to a low of $1.6 million in Q2 2022.
- A 5-year average of $6.3 million and a median of $6.9 million in 2023 frame the typical range for Other Non-Current Assets.
- Annual changes were most pronounced in 2022 — Other Non-Current Assets slumped 39.06% — and 2023, when it jumped 350.55%.
- Tracing BDSX's Other Non-Current Assets over 5 years: stood at $5.9 million in 2022, then increased by 15.8% to $6.9 million in 2023, then rose by 5.85% to $7.3 million in 2024, then grew by 13.36% to $8.2 million in 2025, then decreased by 4.46% to $7.9 million in 2026.
- The last three Other Non-Current Assets figures came in at $7.9 million (Q1 2026), $8.2 million (Q4 2025), and $7.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.40 Bn | 209.33 Bn | 8.34 Bn | 5.62 Bn |
| 2 | Danaher | 139.94 Bn | 135.59 Bn | 3.61 Bn | 4.39 Bn |
| 3 | Idexx Laboratories | 46.03 Bn | 45.83 Bn | 779.09 Mn | 567.73 Mn |
| 4 | Agilent Technologies | 39.69 Bn | 37.88 Bn | 990.00 Mn | 1.18 Bn |
| 5 | Iqvia Holdings | 39.32 Bn | 37.24 Bn | 1.44 Bn | 558.00 Mn |
| 6 | Natera | 38.47 Bn | 37.37 Bn | 696.04 Mn | 51.00 Mn |
| 7 | Illumina | 29.98 Bn | 28.82 Bn | 770.00 Mn | 576.00 Mn |
| 8 | Mettler Toledo International | 28.57 Bn | 28.52 Bn | 650.22 Mn | 448.88 Mn |
| 9 | Quest Diagnostics | 26.21 Bn | 25.58 Bn | 1.03 Bn | 277.00 Mn |
| 10 | Biodesix | 220.06 Mn | 194.49 Mn | 21.35 Mn | 7.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.86 Mn |
| Dec 31, 2025 | 8.23 Mn |
| Sep 30, 2025 | 7.51 Mn |
| Jun 30, 2025 | 7.15 Mn |
| Mar 31, 2025 | 7.30 Mn |
| Dec 31, 2024 | 7.26 Mn |
| Sep 30, 2024 | 6.66 Mn |
| Jun 30, 2024 | 6.56 Mn |
| Mar 31, 2024 | 6.18 Mn |
| Dec 31, 2023 | 6.86 Mn |
| Sep 30, 2023 | 6.97 Mn |
| Jun 30, 2023 | 6.99 Mn |
| Mar 31, 2023 | 6.38 Mn |
| Dec 31, 2022 | 5.92 Mn |
| Sep 30, 2022 | 6.09 Mn |
| Jun 30, 2022 | 1.55 Mn |
| Mar 31, 2022 | 2.01 Mn |
| Dec 31, 2021 | 1.66 Mn |
| Sep 30, 2021 | 2.10 Mn |
| Jun 30, 2021 | 2.55 Mn |